Clinical study of peripheral vascular diseases and treatment modalities
Keywords:
peripheral vascular disease, rest pain, claudication, ilizarov, complication, outcomeAbstract
Peripheral vascular disease is circulation disorders that affect blood vessels outside of the heart and brain. It often neglected by patients but in later stage it causes serious problems. Smoking tobacco is the main culprit for PVD. So, this challenging subject is taken up for the present study in which we will be studying the clinical profile and management modalities for PVD in our hospital. This prospective study was conducted between September 2014 to September 2021on patients admitted to Smt. B. K. Shah Medical Institute and Research Centre, Dhiraj Hospital Piparia Vadodara. 50 patients having symptoms of peripheral vascular disease. This prospective study conducted at S.B.K.S.M.I.R&C. Dhiraj Hospital Piparia Vadodara, included 50 patients with acute pancreatitis, male and female (M: F =41:9),mean age is 35.5 years, smoking is the significant risk factor, medical therapy is more preferable in initial of disease while surgical treatment late phase. Peripheral vascular disease is mainly seen in elderly male specially seen in smokers and tobacco chewer ,claudication ,restpain,ulcer are the main symptoms , management is based upon claudication grading grade 1 and grade 2 can be manged conservatively while grade 3 and 4 required surgical management. Ilizarov, vascular bypass graft.
Downloads
References
Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-51.
Vascular Anatomy of Human body; techmeanatomy; www. Teach Me Anatomy.info.
Francisco, Serraro Hernando , Antonio Martin Conejero. Serrano Hernando FJ et al. Peripheral artery disease; Rev Esp Cardiol 2007;60(9);969-82.
Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1-S75.
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898-904.
Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-7.
Hirsch AT, Treat-Jacobson D, Lando HA, Neaton JD, Dyer AR, Garside DB, et al. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vasc Med. 1997;2:243-51.
Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Acta Med Scand. 1987;221:253-60.
9. Vibu Garg,Sanjay Pandya,Sanket Verma,Deepak Kumar Et Al. A Clinical Study Of Peripheral Vascular Disese With Special Reference To Phophodiesters Inhibitor; ISOR JOURNAL OF MEDICAL AND DENTAL SCIENCE ,jan 2015-16. 144-146.
Ashok Kumar.U Pithva, R.N. Nayak E; A Study Of The Value Of Ilizarov Technique In Thrmboangnitisobliterans; NOV 2003-04 ; 16-23.
Tangelder M, Lawson J, Algra A, Eikelboom B. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in prevention of graft occlusion and ischemic events after infrainguinal bypass surgery. J Vasc Surg. 1999;30:701-9.
Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
El- Sayed bypass surgery for limb salvage: vein bypass ;Methodist Debakey Cardiovasc J. 2012 Oct-Dec; 8(4): 37–42.
Rochestreas,Harry L. Morrison, III, M.D., Ph.D.1, M.D., Ph.D.1 Catheter-Directed Thrombolysis for Acute Limb Ischemia;Semin Intervent Radiol. 2006 Sep; 23(3): 258–69.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
